Skip to main content
BDX
NYSE Industrial Applications And Services

EVP and Interventional Segment President Richard Byrd Announces Retirement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$155.46
Mkt Cap
$44.266B
52W Low
$127.536
52W High
$187.35
52W Position info
22% above low
Off High info
17% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BDX sits 22% above its 52-week low of $127.536.

Summary

Becton Dickinson's Executive Vice President and President of the Interventional segment, Richard E. Byrd, will retire in June, with a successor expected to be named prior to his departure.


Key Events · Executive and Board Changes · BDX

  • Executive Retirement Announced

    Richard E. Byrd, Executive Vice President and President of the Interventional segment, informed BD of his intention to retire in June 2026 after nearly 25 years with the company.

  • Planned Leadership Transition

    Mr. Byrd will remain in his role through June, and Becton Dickinson intends to name a successor prior to his retirement date, indicating a managed transition.

  • Key Segment Leadership

    Byrd has led the Interventional segment since September 2022 and previously held other significant leadership roles, including worldwide president of Medication Delivery Solutions and Preanalytical Systems.


Analysis · BDX · Industrial Applications And Services

Becton Dickinson announced the planned retirement of Richard E. Byrd, Executive Vice President and President of its Interventional segment. This is a significant leadership transition for a key business segment, though the planned nature and intention to name a successor mitigate immediate negative impact. Investors will monitor the announcement of his replacement and any potential strategic shifts within the Interventional segment.

At the time of this filing, BDX was trading at $155.46 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $44.3B. The 52-week trading range was $127.54 to $187.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDX - Latest Insights

BDX
Jun 23, 2026, 6:50 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $140.78
Real-time Price: $156.36 info
Change: +$15.58 (+11%) info
Market Cap: $43.084B info
BDX
May 29, 2026, 8:39 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $148.41
Real-time Price: $156.36 info
Change: +$7.95 (+5%) info
Market Cap: $43.084B info
BDX
May 20, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $146.95
Real-time Price: $156.36 info
Change: +$9.41 (+6%) info
Market Cap: $43.084B info
BDX
May 12, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $147.51
Real-time Price: $156.36 info
Change: +$8.85 (+6%) info
Market Cap: $43.084B info
BDX
May 11, 2026, 6:21 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $143.15
Real-time Price: $156.36 info
Change: +$13.21 (+9%) info
Market Cap: $43.084B info